Skip to main content

Insight Molecular Diagnostics Inc.

IMDX
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
SEC CIK
0001642380

No open-market purchases or sales by Insight Molecular Diagnostics Inc. insiders were filed in the last 90 days; 40 institutions reported holding it in 13F filings for Q2 2026, worth $108.9M in total; no superinvestor holds it.

13F holders, Q3 2022

Institutional positions in Insight Molecular Diagnostics Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
65
−10 vs. Q2 2022
Shares held
66.2M
−2.56M (−3.7%) vs. Q2 2022
Total value
$48.3M
−$13.5M (−21.9%) vs. Q2 2022
New holders
5
10 more added
Sold out
15
23 more reduced

1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting IMDX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2022: 65 institutions
Q1 2021: 87 institutionsQ2 2021: 91 institutionsQ3 2021: 95 institutionsQ4 2021: 89 institutionsQ1 2022: 86 institutionsQ2 2022: 76 institutionsQ3 2022: 65 institutionsQ4 2022: 59 institutionsQ1 2023: 52 institutionsQ2 2023: 47 institutionsQ3 2023: 30 institutionsQ4 2023: 26 institutionsQ1 2024: 25 institutionsQ2 2024: 23 institutionsQ3 2024: 21 institutionsQ4 2024: 27 institutionsQ1 2025: 30 institutionsQ2 2025: 30 institutionsQ3 2025: 27 institutionsQ4 2025: 35 institutionsQ1 2026: 41 institutionsQ2 2026: 40 institutions
Value heldQ3 2022: $48.4M
Q1 2021: $283.0MQ2 2021: $324.6MQ3 2021: $201.9MQ4 2021: $120.3MQ1 2022: $81.2MQ2 2022: $61.9MQ3 2022: $48.4MQ4 2022: $19.6MQ1 2023: $19.7MQ2 2023: $21.1MQ3 2023: $14.3MQ4 2023: $11.4MQ1 2024: $13.5MQ2 2024: $21.1MQ3 2024: $20.4MQ4 2024: $20.0MQ1 2025: $49.2MQ2 2025: $48.9MQ3 2025: $54.1MQ4 2025: $124.9MQ1 2026: $62.1MQ2 2026: $108.9M
Institutions holding IMDX and their total value by quarter
QuarterHoldersValue
Q2 202640$108.9M
Q1 202641$62.1M
Q4 202535$124.9M
Q3 202527$54.1M
Q2 202530$48.9M
Q1 202530$49.2M
Q4 202427$20.0M
Q3 202421$20.4M
Q2 202423$21.1M
Q1 202425$13.5M
Q4 202326$11.4M
Q3 202330$14.3M
Q2 202347$21.1M
Q1 202352$19.7M
Q4 202259$19.6M
Q3 202265$48.4M
Q2 202276$61.9M
Q1 202286$81.2M
Q4 202189$120.3M
Q3 202195$201.9M
Q2 202191$324.6M
Q1 202187$283.0M

Institutions, Q3 2022

Shares, value and share of portfolio for each institution holding Insight Molecular Diagnostics Inc.; share changes are against Q2 2022.

Institutions holding IMDX in Q3 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Broadwood Capital Inc23,353,697$17.0M1.30%00.0%Unchanged
Pura Vida Investments, LLC18,056,274$13.2M1.99%00.0%Unchanged
AWM Investment Company, Inc.7,746,557$5.66M0.86%00.0%Unchanged
Vanguard Group Inc4,356,702$3.18M0.00%+10,172+0.2%Added
Defender Capital, LLC.2,551,980$1.88M0.74%−37,400−1.4%Reduced
BlackRock Inc.2,305,331$1.68M0.00%−38,095−1.6%Reduced
OrbiMed Advisors LLC1,882,768$1.37M0.03%−955,032−33.7%Reduced
Geode Capital Management, LLC994,954$726.0K0.00%+21,632+2.2%Added
Schonfeld Strategic Advisors LLC749,700$547.0K0.00%−207,700−21.7%Reduced
Millennium Management LLC721,386$527.0K0.00%−274,783−27.6%Reduced
Penbrook Management LLC563,350$411.0K0.35%−12,400−2.2%Reduced
Goldman Sachs Group Inc381,532$279.0K0.00%−160,451−29.6%Reduced
ACT Capital Management, LLC330,000$241.0K0.33%00.0%Unchanged
State Street Corp281,845$206.0K0.00%−45,300−13.8%Reduced
Northern Trust Corp208,799$152.0K0.00%00.0%Unchanged
Bridgeway Capital Management, LLC205,300$150.0K0.00%00.0%Unchanged
LPL Financial LLC138,841$101.0K0.00%+30,025+27.6%Added
Fort Sheridan Advisors LLC135,000$99.0K0.03%00.0%Unchanged
Morgan Stanley109,343$80.0K0.00%−39,099−26.3%Reduced
Caliber Wealth Management, LLC75,120$55.0K0.04%00.0%Unchanged
Deutsche Bank AG67,670$49.0K0.00%00.0%Unchanged
Ergoteles LLC64,302$47.0K0.00%−167,831−72.3%Reduced
Bank of America Corp63,203$46.0K0.00%−54,665−46.4%Reduced
Charles Schwab Investment Management Inc62,284$46.0K0.00%00.0%Unchanged
Bank of New York Mellon Corp63,270$46.0K0.00%00.0%Unchanged
Qube Research & Technologies Ltd54,398$40.0K0.00%−4,132−7.1%Reduced
Balyasny Asset Management LLC52,887$39.0K0.00%+42,091+389.9%Added
Wealth Effects LLC51,000$37.0K0.02%+2,000+4.1%Added
Ameriprise Financial Inc45,900$34.0K0.00%+32,100+232.6%Added
Cubist Systematic Strategies, LLC40,718$30.0K0.00%+13,478+49.5%Added
D. E. Shaw & Co., Inc.38,291$28.0K0.00%−43,805−53.4%Reduced
Price T Rowe Associates Inc36,600$27.0K0.00%00.0%Unchanged
LMR Partners LLP31,463$23.0K0.00%00.0%Unchanged
Jane Street Group, LLC30,722$22.0K0.00%+30,722New
Citadel Advisors LLC27,454$20.0K0.00%−224,063−89.1%Reduced
UBS Group AG25,575$19.0K0.00%+5,569+27.8%Added
American Portfolios Advisors21,830$15.9K0.00%00.0%Unchanged
Westshore Wealth, LLC20,000$15.0K0.01%00.0%Unchanged
Creative Planning18,609$14.0K0.00%00.0%Unchanged
National Asset Management, Inc.17,890$14.0K0.00%+17,890New
Raymond James Financial Services Advisors, Inc.16,776$12.0K0.00%00.0%Unchanged
Williams Jones Wealth Management, LLC.15,000$11.0K0.00%00.0%Unchanged
Tower Research Capital LLC (TRC)13,504$10.0K0.00%−1,158−7.9%Reduced
Victory Capital Management Inc12,523$9.00K0.00%−2,628−17.3%Reduced
Y-Intercept (Hong Kong) Ltd11,469$8.37K0.00%−15,527−57.5%Reduced
Virtu Financial LLC10,558$8.00K0.00%−10,183−49.1%Reduced
Levin Capital Strategies, L.P.10,500$8.00K0.00%+10,500New
The PNC Financial Services Group, Inc.10,000$7.00K0.00%00.0%Unchanged
Freestone Capital Holdings, LLC10,000$7.00K0.00%00.0%Unchanged
JPMorgan Chase & Co7,808$6.00K0.00%+1,446+22.7%Added
BNP Paribas Arbitrage, SA6,269$4.58K0.00%−6,988−52.7%Reduced
Royal Bank of Canada4,342$3.00K0.00%+3,748+631.0%Added
Group One Trading, L.P.2,622$2.00K0.00%−300−10.3%Reduced
Advisor Group Holdings, Inc.2,840$2.00K0.00%00.0%Unchanged
Federated Hermes, Inc.2,420$2.00K0.00%+2,420New
Citigroup Inc872$1.00K0.00%−2,648−75.2%Reduced
Wells Fargo & Company771$1.00K0.00%−37−4.6%Reduced
Riggs Asset Managment Co. Inc.1,000$1.00K0.00%00.0%Unchanged
China Universal Asset Management Co., Ltd.1,111$1.00K0.00%+1,111New
US Bancorp500$00.00%00.0%Unchanged
Meeder Asset Management Inc195$00.00%−447−69.6%Reduced
Albion Financial Group152$00.00%00.0%Unchanged
Lindbrook Capital, LLC86$00.00%00.0%Unchanged
Piscataqua Savings Bank500$00.00%00.0%Unchanged
IFP Advisors, Inc32,001––00.0%Unchanged
Gsa Capital Partners LLP0$00.00%−160,238−100.0%Sold out
Susquehanna International Group, LLP0$00.00%−145,804−100.0%Sold out
Cambridge Investment Research Advisors, Inc.0$00.00%−36,500−100.0%Sold out
Jump Financial, LLC0$00.00%−29,140−100.0%Sold out
DCF Advisers, LLC0$00.00%−25,149−100.0%Sold out
Two Sigma Securities, LLC0$00.00%−21,217−100.0%Sold out
Cinctive Capital Management LP0$00.00%−19,565−100.0%Sold out
Engineers Gate Manager LP0$00.00%−17,139−100.0%Sold out
HRT Financial LP0$00.00%−13,941−100.0%Sold out
FMR LLC0$00.00%−6,078−100.0%Sold out
Captrust Financial Advisors0$00.00%−4,503−100.0%Sold out
New York State Common Retirement Fund0$00.00%−573−100.0%Sold out
Barclays PLC0$00.00%−41−100.0%Sold out
Credit Suisse AG0$00.00%−32−100.0%Sold out
CoreCap Advisors, LLC0$00.00%−5−100.0%Sold out
B. Riley Wealth Management, Inc.––––Not filed